The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
// COMPARISON

BPC-157 vs TB-500: Complete 2026 Comparison

Side-by-side comparison of BPC-157 and TB-500: mechanism, common use cases, dosing protocols from named experts, vendor availability, and expert opinion. Both are framed as research compounds.

TL;DR Table

FactorBPC-157TB-500
ClassPEPTIDEPEPTIDE
Aliases["Body Protection Compound 157", "Pentadecapeptide"]["Thymosin Beta-4 fragment", "TB500"]
MechanismPromotes angiogenesis (new blood vessel formation), modulates nitric oxide, upregulates growth hormone receptors locally.Binds G-actin, promotes cell migration during tissue repair. Upregulates VEGF and stem cell mobilization.
What it's researched forAccelerates tendon, ligament, muscle, and gut healing. Some evidence for neuroprotection. Tanner uses BPC-157 from APR for soft tissue healing.Accelerates wound and tissue healing, especially in muscle, tendon, and skin. Often co-administered with BPC-157.
Dosing mentions tracked10463
Vendor recs tracked3626
PubMed papers158

Mechanism Comparison

BPC-157

Promotes angiogenesis (new blood vessel formation), modulates nitric oxide, upregulates growth hormone receptors locally.

Full BPC-157 profile →

TB-500

Binds G-actin, promotes cell migration during tissue repair. Upregulates VEGF and stem cell mobilization.

Full TB-500 profile →

What Each is Researched For

BPC-157 research areas

Accelerates tendon, ligament, muscle, and gut healing. Some evidence for neuroprotection. Tanner uses BPC-157 from APR for soft tissue healing.

TB-500 research areas

Accelerates wound and tissue healing, especially in muscle, tendon, and skin. Often co-administered with BPC-157.

Dosing Mention Comparison

BPC-157 dosing

  • speaker_1: Speaker reported using 200-1,000 mcg BPC-157 via subcutaneous, intramuscular, or intra-articular injection positioned as close to soft... (00:00:22)
  • speaker_1: Speaker discussed injury recovery: serious tissue damage addressed with 3-month treatment cycles rather than 3-week protocols. No... (00:00:29)
  • Narrator: A clinic reportedly offers a 'glow stack' combining GHK copper, BPC-157, and TB-500, marketed for anti-aging, recovery, and inflammation... (00:00:47)
  • narrator: Users report oral BPC-157 for gut inflammation; injectable BPC-157 for chronic systemic inflammation and multiple joint issues. (00:00:50)
  • speaker_1: Single oral dose of either 1 mg, 3 mg, or 6 mg BPC-157 on an empty stomach during phase 1A of the PCO-02 trial. (00:00:55)

TB-500 dosing

  • speaker_1: Speaker reported discussing TB-500 as part of a properly dosed Wolverine injury cycle, noting that recovery from serious tissue damage... (00:00:29)
  • Narrator: Included as part of a clinic 'glow stack' with GHK copper, BPC-157, and TB-500 for anti-aging, recovery, and inflammation reduction; no... (00:00:47)
  • Speaker1: Pharmaceutical grade at therapeutic doses; pharmacy grade from a 503A compounding facility specified as the standard. No specific mg... (00:00:56)
  • Dr. Jones DC: Dr. Jones DC's anecdotal protocol includes TB-500 as one of three peptides in a 'Glow' stack with GHK copper and BPC-157 for broader... (00:03:27)
  • speaker_1: Common injury protocol described by speaker_1 (source: 3MSSSxeqE9k): 500 mcg to 1 mg TB-500 with 500 mcg to 1 mg BPC-157, injected as... (00:04:06)

Side Effect Notes

Anecdotal reports for both compounds vary by route, dose, and individual. Neither should be treated as an approved medication. Consult a qualified clinician.

When To Choose Which

Comparison depends on research question, available source quality, and individual risk tolerance. See the full profiles for BPC-157 and TB-500 for context-specific details.

Can You Stack Them?

Stacking decisions should be evaluated by qualified professionals with attention to dose attribution, source quality, and outcome tracking. This page is a research aggregator and does not recommend stacking protocols.

FAQ

Which has more research?

BPC-157 has 15 PubMed citations indexed; TB-500 has 8.

Which has more vendor coverage?

BPC-157: 36 tracked vendor recommendations. TB-500: 26.

Are they approved drugs?

Both are framed on this site as research compounds. Verify current FDA status and state-specific rules before any decision.

Where do I read more?

See BPC-157 and TB-500 for full profiles with all dosing mentions and PubMed citations.